{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:45:31Z","timestamp":1768967131602,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.juro.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T18:03:54Z","timestamp":1342807434000},"page":"748-753","source":"Crossref","is-referenced-by-count":21,"title":["The Value of Transurethral Bladder Biopsy after Intravesical Bacillus Calmette-Gu\u00e9rin Instillation Therapy for Nonmuscle Invasive Bladder Cancer: A Retrospective, Single Center Study and Cumulative Analysis of the Literature"],"prefix":"10.1097","volume":"188","author":[{"given":"Natalia","family":"Swietek","sequence":"first","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Waldert","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Rom","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Schatzl","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene G.","family":"Wiener","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Susani","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[{"name":"Departments of Urology and Clinical Pathology (HGW, MS), Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.05.015_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer\u2013Genito-Urinary Group Phase III Trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.05.015_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00005392-199909010-00020","article-title":"Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?","volume":"162","author":"Dalbagni","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0090-4295(01)01496-0","article-title":"Routine bladder biopsy after bacille Calmette-Guerin treatment: is it necessary?","volume":"59","author":"Skemp","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.05.015_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2006.03.022","article-title":"Should bladder biopsies be performed routinely after bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder?","volume":"50","author":"Guy","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib8","first-page":"341","article-title":"Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus Calmette-Guerin therapy","volume":"61","author":"Murakami","year":"2007","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.juro.2012.05.015_bib9","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib10","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","article-title":"Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","volume":"174","author":"Herr","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.juro.2012.05.015_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1442-2042.2008.02200.x","article-title":"Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after bacille Calmette-Guerin intravesical therapy","volume":"16","author":"Hara","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1078-1439(02)00239-9","article-title":"Is bladder biopsy necessary at three or six months post BCG therapy?","volume":"21","author":"Highshaw","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2012.05.015_bib14","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1111\/j.1464-410X.2010.09980.x","article-title":"Early vs delayed radical cystectomy for \u2018high-risk\u2019 carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival","volume":"108","author":"J\u00e4ger","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.05.015_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000030495","article-title":"Cytological changes induced by intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer","volume":"64","author":"Takashi","year":"2000","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2012.05.015_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000282609","article-title":"Diagnostic problems of urine cytology on initial follow-up after intravesical immunotherapy with Calmette-Guerin bacillus for superficial bladder cancer","volume":"52","author":"Mack","year":"1994","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2012.05.015_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-5347(17)32744-1","article-title":"Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence","volume":"152","author":"Schwalb","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2007.03.001","article-title":"Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guerin therapy","volume":"52","author":"Mengual","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.ju.0000149825.83180.a4","article-title":"Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization","volume":"173","author":"Kipp","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib20","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1002\/ijc.24258","article-title":"The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical bacillus Calmette-Guerin therapy","volume":"124","author":"Savic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2012.05.015_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0302-2838(03)00157-X","article-title":"Significance of random bladder biopsies in superficial bladder cancer","volume":"44","author":"May","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000049828","article-title":"Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions","volume":"40","author":"Oosterlinck","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.eururo.2010.01.025","article-title":"Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations","volume":"57","author":"Witjes","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.eururo.2009.09.037","article-title":"Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guerin immunotherapy and mitomycin C intravesical therapy","volume":"57","author":"Draga","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.05.015_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/end.2008.0642","article-title":"Hexylaminolevulinate photodynamic diagnosis for multifocal recurrent nonmuscle invasive bladder cancer","volume":"23","author":"Ray","year":"2009","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2012.05.015_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/end.2010.0042","article-title":"Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging","volume":"24","author":"Naselli","year":"2010","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2012.05.015_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin","volume":"62","author":"Palou","year":"2011","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712037135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712037135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.05.015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:57:08Z","timestamp":1651201028000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.05.015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1016\/j.juro.2012.05.015"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.05.015","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}